Gemtuzumab ni iki: Ibikoreshwa, Urutonde rw'imiti, Ingaruka zayo n'ibindi

Gemtuzumab ni umuti w'indwara ya kanseri ugamije, uhuza umubiri urwanya indwara n'umuti wa chemotherapy uvura ubwoko bumwe bwa kanseri y'amaraso yitwa acute myeloid leukemia (AML). Ubu buvuzi bwihariye bukora nk'igisasu kiyobora, gishakisha uturemangingo twa kanseri twihariye naho tundi turemangingo twiza tukareka.

Niba wowe cyangwa umuntu witaweho yarandikiwe gemtuzumab, birashoboka ko wumva uhangayitse ufite ibibazo byinshi. Ibyo ni ibisanzwe kandi birumvikana. Uyu muti uhagarariye icyizere ku bantu benshi bahanganye na AML, kandi gusobanukirwa uko ikora birashobora kugufasha kumva ufite icyizere cyinshi ku rugendo rwawe rw'ubuvuzi.

Gemtuzumab ni iki?

Gemtuzumab ni umuti uhuza umubiri urwanya indwara, bivuze ko ari imiti ibiri ikomeye ihuriye hamwe. Igice cy'umubiri urwanya indwara gikora nk'igikoresho cyo gushaka gisanga uturemangingo twa kanseri dufite poroteyine yihariye yitwa CD33 ku ruhu rwabo. Iyo imaze gufata kuri utwo turemangingo, itanga umuti wa chemotherapy ukomeye muri bo.

Tekereza nk'uburyo bwo gutanga bugamije bushobora gutandukanya uturemangingo twa kanseri n'uturemangingo twiza. Ubu buryo bw'ukuri bufasha kugabanya kwangirika ku bice bisanzwe mugihe cyibanda ku buvuzi aho bikenerwa cyane. Uyu muti witwa Mylotarg kandi ukaba mu cyiciro cy'imiti yitwa imibiri irwanya indwara ya monoclonal.

Ubu buvuzi bugenewe by'umwihariko kanseri y'amaraso ya acute myeloid leukemia, ubwoko bwa kanseri y'amaraso igira ingaruka ku turemangingo twera tw'amaraso. Poroteyine ya CD33 iboneka ku turemangingo twinshi twa AML, bituma gemtuzumab iba uburyo bwiza ku barwayi benshi bafite iyi ndwara.

Gemtuzumab ikoreshwa mu kuvura iki?

Gemtuzumab ikoreshwa cyane cyane mu kuvura kanseri y'amaraso ya acute myeloid leukemia mu bantu bakuru n'abana bafite imyaka irenga 2. Muganga wawe azagusaba uyu muti mugihe uturemangingo twawe twa kanseri tugaragaje ko dufite poroteyine ya CD33, ibyo bikaba bibaho mu byegeranyo 90% bya AML.

Uyu muti akenshi ukoreshwa hamwe n'indi miti ya kanseri yitwa chemotherapy nka daunorubicin na cytarabine ku bantu bashya bafite indwara ya AML. Ubu buryo bwo guhuza imiti bwagaragaje umusaruro mwiza kurusha gukoresha chemotherapy yonyine. Itsinda ry'abaganga bakuvura bazagena gahunda nziza yo kuvura ishingiye ku miterere yawe, imyaka yawe, n'ubuzima bwawe muri rusange.

Mu bindi bihe, gemtuzumab ishobora gukoreshwa nk'umuti umwe ku barwayi batabasha kwihanganira chemotherapy ikaze. Ibi bishobora gukoreshwa ku bantu bakuze cyangwa abafite izindi ndwara zituma chemotherapy isanzwe iba iy'akaga cyane.

Gemtuzumab ikora ite?

Gemtuzumab ikora ikoresheje uburyo bubiri bukomeye bugamije selile za kanseri mu buryo bwihariye. Mbere na mbere, igice cy'umubiri cy'umubiri kimenya kandi kigafatana na poroteyine ya CD33 ku ruhu rwa selile za AML. Ibi bimeze nk'urufunguzo rubona urufunguzo rwarwo rwihariye.

Iyo imaze gufatana, selile ya kanseri ikurura molekile yose ya gemtuzumab imbere binyuze mu buryo bwo kwinjizwa. Imbere muri selile, igice cya chemotherapy (cyitwa calicheamicin) kirarekurwa kandi gitangira kurimbura selile ya kanseri imbere. Ubu buryo bugamije busobanura ko umuti ukomeye wa chemotherapy utangwa mu buryo butaziguye aho ukenewe.

Ibi bifatwa nk'umuti wa kanseri ukomeye. Nubwo ifite imbaraga zihagije zo kwica selile za kanseri neza, uburyo bwo gutanga bugamije bufasha kugabanya ingaruka zikwirakwira ushobora guhura nazo hamwe na chemotherapy isanzwe. Ariko, ni ubuvuzi bukomeye bugomba gukurikiranwa neza n'ikipe yawe y'abaganga.

Nkwiriye gufata gemtuzumab nte?

Gemtuzumab itangwa nk'urushinge rwinjizwa mu maraso yawe binyuze mu urwungano rw'imitsi. Ntushobora gufata uyu muti unywa mu kanwa, kandi ugomba gutangwa mu bitaro cyangwa ikigo cyihariye cyo kuvura kanseri n'abakozi b'ubuzima babihuguriwe.

Mbere yo gutera urushinge, itsinda ryawe ry'abaganga rizaguhereza imiti yo gufasha kwirinda ibimenyetso by'uburwayi. Iyi miti ikunze kuba irimo imiti irwanya allergie nka diphenhydramine na acetaminophen kugabanya umuriro no kutagira umunezero. Ntabwo ukeneye kwirinda kurya mbere yo kuvurwa, ariko kuguma ufite amazi menshi unywa amazi menshi ni ingenzi.

Urushinge ubwarwo akenshi rufata hafi amasaha 2, kandi uzagenzurwa cyane mugihe cyo kuvurwa no nyuma yaho. Itsinda ryawe ry'ubuzima rizagenzura ibimenyetso byose by'uburwayi cyangwa izindi ngaruka. Teganya kumara umunsi wose ku kigo kivurirwamo, kuko igihe cyo kugenzura cyongerewe gikunze gukenerwa.

Ushobora kumva umeze neza uzanye igitabo, tablet, cyangwa ufite inshuti cyangwa umuryango ugusanga mugihe cyo kuvurwa. Abantu benshi basanga uburyo bwo gutera urushinge butabangamira cyane iyo bafite ikintu cyo gukoresha ubwenge bwabo.

Nzamara Igihe Kingana Gite Nkorera Gemtuzumab?

Igihe cyo kuvurwa na gemtuzumab giterwa n'uburyo bwawe bwihariye bwo kuvura n'uburyo wumva imiti. Abantu benshi bakira gemtuzumab nk'igice cyo kuvura, akenshi bikubiyemo ibizunguruka 1-2 bitangwa muminsi mike.

Niba wakira imiti ivanze n'indi miti ya chimiothérapie, ushobora guhabwa gemtuzumab kumunsi wa 1, 4, na 7 y'umuzunguruko wawe wa mbere wo kuvura. Kubarwayi bakira gemtuzumab bonyine, gahunda akenshi iba itandukanye, akenshi ikubiyemo imiti itandukanyijwe nibura mu byumweru 2.

Muganga wawe azagenzura buri gihe imibare y'amaraso yawe n'uburyo wumva imiti kugirango amenye niba doze zindi zikenewe. Abantu bamwe bashobora kwakira gemtuzumab mugihe cyo kuvura, biza nyuma y'icyiciro cyo kuvura. Umubare wose wa doze ntarenga imiti 3-4.

Ni ngombwa kurangiza uburyo bwose bwo kuvura nkuko byateganijwe, nubwo utangiye kumva umeze neza. Guhagarika kare byatuma selile za kanseri zongera gukura kandi zikaba zigoye kuvura.

Ni Iyihe Ngaruka za Gemtuzumab?

Kimwe n'imiti yose ya kanseri, gemtuzumab ishobora gutera ingaruka ziterwa n'imiti, nubwo atari buri wese uzagira izo ngaruka zose. Kumenya ibyo witegura bishobora kugufasha kwitegura no kumenya igihe cyo kuvugana n'ikipe yawe y'ubuvuzi.

Ingaruka zikunze kugaragara ushobora guhura nazo zirimo umunaniro, umuriro, isesemi, no kugabanuka kw'uturemangingo tw'amaraso. Izi ngaruka zikunda kuza mu minsi mike nyuma yo kuvurwa kandi akenshi ziragenda uko umubiri wawe wimenyereza.

Dore ingaruka ziterwa n'imiti zikunze kugaragara, zateguwe kuva ku zikunze kugaragara cyane kugeza ku zitagaragara cyane:

• Umunaniro n'intege nke bishobora kumara iminsi myinshi
• Umuriro n'ubukonje, cyane cyane mu masaha 24 nyuma yo kuvurwa
• Isesemi no kuruka, akenshi bishobora gucungwa n'imiti
• Kugabanuka kw'uturemangingo tw'amaraso twera, bikongera ibyago byo kwandura indwara
• Kugabanuka kw'uturemangingo tw'amaraso dutukura, bituma gukomereka cyangwa kuva amaraso byoroha
• Umutwe n'izunguzwa
• Ibisebe mu kanwa cyangwa kuribwa mu muhogo
• Uruhu rurashye cyangwa kurigata

Izi ngaruka zisanzwe ziterwa n'imiti akenshi zicungwa neza n'ubufasha n'imiti muganga wawe ashobora kugutera. Abantu benshi basanga izi ngaruka zigabanuka mu cyumweru kimwe cyangwa bibiri nyuma yo kuvurwa buri gihe.

Hariho kandi ingaruka zimwe na zimwe zitagaragara ariko zikomeye zisaba ubufasha bwihuse bw'ubuvuzi. Nubwo ibi bitabaho ku barwayi benshi, ni ngombwa kubimenya kugirango ushobore gushaka ubufasha vuba niba bibaye ngombwa.

Ingaruka zitagaragara ariko zikomeye zirimo:

• Ibibazo bikomeye by'umwijima, harimo indwara yitwa veno-occlusive disease
• Urugero rukomeye rwo kwibasirwa n'umubiri mu gihe cyo kuvurwa
• Indwara zikomeye ziterwa no kugabanuka cyane kw'uturemangingo tw'amaraso twera
• Ibibazo bikomeye byo kuva amaraso bitewe no kugabanuka cyane kw'uturemangingo tw'amaraso dutukura
• Ibibazo by'umutima cyangwa kwangirika kw'imitsi y'umutima
• Ibibazo bikomeye by'ibihaha cyangwa guhumeka bigoranye

Itsinda ryawe rishinzwe ubuzima rizagukurikiranira hafi ibi bintu bikomeye binyuze mu bipimo by'amaraso bisanzwe n'ibizamini by'umubiri. Niba wumva guhumeka bigoye cyane, kubabara mu gituza, umuhondo w'uruhu rwawe cyangwa amaso yawe, cyangwa ibimenyetso by'indwara ikomeye, vugana n'umuganga wawe ako kanya.

Ninde utagomba gufata Gemtuzumab?

Gemtuzumab ntikwiriye kuri buri wese, kandi umuganga wawe azasuzuma neza niba ari wo mwanzuro ukwiriye kuri wowe. Abantu bafite ibibazo by'ubuzima runaka cyangwa ibihe runaka bashobora gukenera imiti itandukanye.

Ntugomba guhabwa gemtuzumab niba ufite allergie ikomeye izwi ku muti cyangwa kimwe mu bigize wo. Byongeye kandi, niba selile za kanseri yawe zitagira poroteyine ya CD33, ubu buvuzi ntibuzagira akamaro kuri wowe.

Ugomba gushobora gukoresha gemtuzumab niba ufite:

• Indwara ikomeye y'umwijima cyangwa amateka y'ibibazo by'umwijima
• Indwara zikomeye zitagenzurwa
• Umubare muto cyane wa selile z'amaraso zitagira icyo zikora n'ubufasha
• Ibibazo bikomeye by'umutima cyangwa umutima wahagaze vuba aha
• Gusama cyangwa imigambi yo gusama

Ubwitange bwihariye bukenewe ku bantu bakuze, kuko bashobora kwitwara neza ku ngaruka ziterwa. Umuganga wawe azagereranya inyungu zishoboka n'ibibazo bishingiye ku buzima bwawe muri rusange n'izindi ndwara.

Izina ry'ubwoko bwa Gemtuzumab

Gemtuzumab igurishwa ku izina ry'ubwoko rya Mylotarg. Iri ni ryo zina ry'ubwoko rimwe ririho kuri uyu muti muri Leta Zunze Ubumwe z'Amerika no mu bindi bihugu byinshi.

Mylotarg yabanje kwemezwa na FDA mu mwaka wa 2000, ikurwa ku isoko mu mwaka wa 2010 kubera impungenge z'umutekano, hanyuma yongera kwemezwa mu mwaka wa 2017 hamwe n'inama zigezweho zo gupima. Ubu buryo bufatwa nk'ubutekanye kandi bufite akamaro kurusha ubwa mbere.

Igihe wakira imiti yawe, uruvange rw'imiti ruzaba rwanditseho Mylotarg. Muri iki gihe nta miti ya gemtuzumab iboneka mu buryo rusange, kuko iyi ari imiti yihariye cyane isaba uburyo bwo kuyikora bugoye.

Uburyo bwo gusimbura Gemtuzumab

Niba gemtuzumab idakwiriye mu bihe byawe, hari imiti myinshi isimbura ivura kanseri ya acute myeloid leukemia. Muganga wawe azagufasha kumenya uburyo bwiza bushingiye ku bwoko bwawe bwihariye bwa AML, imyaka yawe, n'ubuzima bwawe muri rusange.

Uburyo busanzwe bwo kuvura kanseri hakoreshejwe imiti nka "7+3" (cytarabine hamwe na daunorubicin) bugikoreshwa cyane mu kuvura AML ku barwayi benshi. Ubu buryo bumaze gukoreshwa neza mu myaka myinshi kandi bushobora gukwira neza niba ufite ibibazo by'ubuzima runaka.

Uburyo bundi bwo kuvura bugamije ahantu runaka bushobora kuba uburyo bwiza bitewe n'imiterere ya kanseri yawe:

• Midostaurin kuri AML ya FLT3-positive
• Enasidenib kuri AML ya IDH2-mutated
• Ivosidenib kuri AML ya IDH1-mutated
• Venetoclax ivanze n'imiti mike ya kanseri

Ku barwayi batabasha kwihanganira imiti ikaze ya kanseri, uburyo bworoshye nka hypomethylating agents (azacitidine cyangwa decitabine) bushobora gutekerezwa. Ubu buryo bwo kuvura buroroshye ariko bugatanga umusaruro ku bantu benshi barwaye AML.

Ese Gemtuzumab iruta imiti isanzwe ya kanseri?

Gemtuzumab ivanze n'imiti isanzwe ya kanseri yagaragaje umusaruro mwiza ugereranije n'imiti ya kanseri yonyine mu igerageza ryinshi ryo kwa muganga. Ubushakashatsi bwagaragaje ko ubuzima bw'abarwayi burushaho kuba burebure kandi imiti ikavura neza iyo gemtuzumab yongerwa mu buryo busanzwe bwo kuvura kanseri.

Igerageza rya ALFA-0701, rimwe mu bushakashatsi bunini, ryagaragaje ko kongerera gemtuzumab ku miti isanzwe ya kanseri byongereye ubuzima muri rusangeho amezi menshi. Ibi byagaragaye cyane ku barwayi bafite imiterere myiza ya genetike ya kanseri yabo.

Ariko, "neza" biterwa n'uko ubuzima bwawe bumeze. Nubwo uburyo bwo guhuza imiti bushobora gutanga uburyo bwo kurwanya kanseri neza, buzanana n'ingaruka zindi kandi bisaba gukurikiranwa cyane. Muganga wawe azagufasha gupima ibi bintu bitewe n'imyaka yawe, uko ubuzima bwawe bumeze, n'intego z'ubuvuzi.

Ku barwayi bamwe, cyane cyane abantu bakuze cyangwa abafite izindi ndwara, imiti yoroheje ishobora kuba ikwiriye nubwo ishobora kuba itarwanya kanseri cyane. Ubuvuzi bwiza ni buri gihe ubwo buguha uburinganire bwiza bw'ubushobozi n'ubuzima bwiza.

Ibikunze Kubazwa Kuri Gemtuzumab

Ese Gemtuzumab irakwiriye ku bantu barwaye indwara y'umwijima?

Gemtuzumab ishobora kuba ikomeye cyane ku bantu bafite ibibazo by'umwijima. Uyu muti ushobora gutera indwara ikomeye yitwa hepatic veno-occlusive disease, ifunga imigezi y'amaraso mu mwijima kandi ishobora guteza akaga ku buzima.

Niba ufite ibibazo byoroheje by'umwijima, muganga wawe ashobora gushaka gukoresha gemtuzumab ariko azagukurikiranira hafi cyane akoresheje ibizamini by'amaraso kenshi. Ariko, niba ufite indwara y'umwijima yo hagati cyangwa ikomeye, muganga wawe ashobora gushyira imbere ubuvuzi bundi butagira akaga ku mwijima wawe.

Mbere yo gutangira ubuvuzi, ikipe yawe y'ubuzima izasuzuma neza imikorere y'umwijima wawe ikoresheje ibizamini by'amaraso ndetse n'ibishobora kugaragaza ishusho. Ibi bibafasha kumenya niba gemtuzumab ikwiriye kuri wowe no gushyiraho ibipimo by'ibanze byo gukurikiranwa mugihe cy'ubuvuzi.

Nigomba gukora iki niba mbonye gemtuzumab nyinshi mu buryo butunganye?

Gukoresha gemtuzumab nyinshi ntibishoboka kuko itangwa n'abantu b'inzobere mu buvuzi mu buryo bugenzurwa. Ariko, niba ucyeka ko hari ikosa ryabayeho cyangwa ukagira ibimenyetso bikomeye mugihe cyangwa nyuma y'ubuvuzi, menyesha ikipe yawe y'ubuvuzi ako kanya.

Ibimenyetso byerekana ko ushobora kuba wamaze umuti mwinshi bishobora kuba birimo isesemi rikomeye, kuruka, kunanirwa cyane, cyangwa ibimenyetso bidasanzwe bisa nkaho byiyongereye cyane kurusha uko byari byitezwe. Itsinda ryawe ryita ku buzima rizakugenzura neza kandi rigutange ubufasha kugira ngo ukemure ibibazo byose.

Nta muti wihariye wa gemtuzumab, bityo kuvura bishingira ku gucunga ibimenyetso no gushyigikira umubiri wawe mu gukira. Ibi bishobora kuba birimo imiti yo kugenzura isesemi, amazi ya IV yo kwirinda kumuka, no kugenzura neza imibare y'amaraso yawe.

Nkwiriye gukora iki niba nciwe urugero rwa gemtuzumab?

Kubera ko gemtuzumab itangwa mu bitaro cyangwa ikigo kivurirwamo hakurikijwe gahunda yihariye, gucikwa urugero mubisanzwe ntabwo ari ikintu kibaho ku buryo butunguranye. Itsinda ryawe ryita ku buzima ritegura neza buri gihe cyo kuvurwa nk'igice cy'uburyo bwawe bwose bwo kuvura.

Niba ukeneye gusubika urugero rwatanzwe kubera uburwayi, imibare mike y'amaraso, cyangwa izindi ngorane z'ubuzima, muganga wawe azagena uburyo bwiza. Rimwe na rimwe kuvurwa birashobora gutinda iminsi mike cyangwa ibyumweru kugeza igihe umubiri wawe witeguye gufata umuti mu buryo butekanye.

Ntuzigere ugerageza gusubiza urugero rwacitse ukubye kabiri urukurikira. Muganga wawe azahindura gahunda yawe yo kuvura uko bikwiye mugihe cyo gukomeza umutekano n'ubushobozi bwo kuvura kwawe. Kuganira n'itsinda ryawe ryita ku buzima ni ingenzi mugucunga impinduka zose z'igihe.

Nshobora guhagarika ryari gufata gemtuzumab?

Mubisanzwe ntabwo “uhagarika” gemtuzumab mu buryo busanzwe, kuko itangwa nk'inzira ngufi yo kuvura aho kuba umuti ukomeza. Abantu benshi barwara bahabwa umubare wagenwe w'ingero nk'igice cy'umugambi wabo wo kuvura.

Muganga wawe azagena igihe kuvurwa kwawe kwa gemtuzumab kurangiriye hashingiwe ku buryo wakiriye kuvurwa n'uburyo bwawe bwose bwo kuvura. Iyi myanzuro irimo gusuzuma uburyo leukemia yawe yitabiriye neza niba witeguye igice gikurikira cyo kuvurwa.

Mu bihe bimwe na bimwe, imiti irashobora guhagarikwa hakiri kare niba uhuye n'ingaruka zikomeye cyangwa niba kanseri yawe ititabira nk'uko byari byitezwe. Itsinda ryawe ry'ubuvuzi rihora rishyira imbere umutekano wawe n'imibereho myiza mugihe bafata izi myanzuro.

Nshobora gutwita niba ndimo gufata Gemtuzumab?

Gemtuzumab irashobora guteza ingaruka zikomeye ku mwana utaravuka, bityo gutwita bigomba kwirindwa mugihe cy'imiti no mumyaka myinshi nyuma yaho. Abagabo n'abagore bagomba gukoresha uburyo bwo kuboneza urubyaro bukora neza mugihe bakira iyi miti.

Niba uri umugore ufite imyaka yo kubyara, muganga wawe ashobora gusaba ikizamini cyo kumenya niba utwite mbere yo gutangira imiti. Ugomba gukomeza gukoresha uburyo bwo kuboneza urubyaro bwizewe byibuze amezi 7 nyuma ya dose yawe ya nyuma ya gemtuzumab.

Abagabo bagomba kandi gukoresha uburyo bwo kuboneza urubyaro mugihe cy'imiti no byibuze amezi 4 nyuma ya dose yabo ya nyuma, kuko imiti ishobora kugira ingaruka ku ntanga kandi ikaba yagira ingaruka ku mwana ukura. Niba uteganya kugira abana mu gihe kizaza, ganira kubijyanye no kubungabunga ubuzima bw'imyororokere na muganga wawe mbere yo gutangira imiti.